Vanguard Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $318K | Hold |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $2.41M | Sell |
|
|||||
|
2021
Q4 | $4.79M | Sell |
|
|||||
|
2021
Q3 | $5.83M | Buy |
|
|||||
|
2021
Q2 | $6.95M | Buy |
|
|||||
|
2021
Q1 | $5.44M | Buy |
|
|||||
|
2020
Q4 | $2.56M | Buy |
|
|||||
|
2020
Q3 | $2.56M | Sell |
|
|||||
|
2020
Q2 | $3.39M | Sell |
|
|||||
|
2020
Q1 | $2.44M | Sell |
|
|||||
|
2019
Q4 | $4.53M | Sell |
|
|||||
|
2019
Q3 | $3.1M | Buy |
|
|||||
|
2019
Q2 | $8.84M | Buy |
|
|||||
|
2019
Q1 | $1.75M | Buy |
|
|||||
|
2018
Q4 | $544K | Buy |
|